Mia T Minen1, Adama Jalloh2, Emma Ortega3, Scott W Powers4, Mary Ann Sevick5, Richard B Lipton. 1. Departments of Neurology and Population Health, NYU Langone Medical Center, New York, New York. 2. City College of New York, New York, New York. 3. Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital, Cincinnati, Ohio. 4. Department of Population Health, NYU Langone Medical Center, New York, New York. 5. Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA.
Abstract
OBJECTIVE: Scalable nonpharmacologic treatment options are needed for chronic pain conditions. Migraine is an ideal condition to test smartphone-based mind-body interventions (MBIs) because it is a very prevalent, costly, disabling condition. Progressive muscle relaxation (PMR) is a standardized, evidence-based MBI previously adapted for smartphone applications for other conditions. We sought to examine the usability of the RELAXaHEAD application (app), which has a headache diary and PMR capability. METHODS: Using the "Think Aloud" approach, we iteratively beta-tested RELAXaHEAD in people with migraine. Individual interviews were conducted, audio-recorded, and transcribed. Using Grounded Theory, we conducted thematic analysis. Participants also were asked Likert scale questions about satisfaction with the app and the PMR. RESULTS: Twelve subjects participated in the study. The mean duration of the interviews (SD, range) was 36 (11, 19-53) minutes. From the interviews, four main themes emerged. People were most interested in app utility/practicality, user interface, app functionality, and the potential utility of the PMR. Participants reported that the daily diary was easy to use (75%), was relevant for tracking headaches (75%), maintained their interest and attention (75%), and was easy to understand (83%). Ninety-two percent of the participants would be happy to use the app again. Participants reported that PMR maintained their interest and attention (75%) and improved their stress and low mood (75%). CONCLUSIONS: The RELAXaHEAD app may be acceptable and useful to migraine participants. Future studies will examine the use of the RELAXaHEAD app to deliver PMR to people with migraine in a low-cost, scalable manner.
OBJECTIVE: Scalable nonpharmacologic treatment options are needed for chronic pain conditions. Migraine is an ideal condition to test smartphone-based mind-body interventions (MBIs) because it is a very prevalent, costly, disabling condition. Progressive muscle relaxation (PMR) is a standardized, evidence-based MBI previously adapted for smartphone applications for other conditions. We sought to examine the usability of the RELAXaHEAD application (app), which has a headache diary and PMR capability. METHODS: Using the "Think Aloud" approach, we iteratively beta-tested RELAXaHEAD in people with migraine. Individual interviews were conducted, audio-recorded, and transcribed. Using Grounded Theory, we conducted thematic analysis. Participants also were asked Likert scale questions about satisfaction with the app and the PMR. RESULTS: Twelve subjects participated in the study. The mean duration of the interviews (SD, range) was 36 (11, 19-53) minutes. From the interviews, four main themes emerged. People were most interested in app utility/practicality, user interface, app functionality, and the potential utility of the PMR. Participants reported that the daily diary was easy to use (75%), was relevant for tracking headaches (75%), maintained their interest and attention (75%), and was easy to understand (83%). Ninety-two percent of the participants would be happy to use the app again. Participants reported that PMR maintained their interest and attention (75%) and improved their stress and low mood (75%). CONCLUSIONS: The RELAXaHEAD app may be acceptable and useful to migraineparticipants. Future studies will examine the use of the RELAXaHEAD app to deliver PMR to people with migraine in a low-cost, scalable manner.
Authors: Sheryl R Haut; Richard B Lipton; Susannah Cornes; Alok K Dwivedi; Rachel Wasson; Sian Cotton; Jeffrey R Strawn; Michael Privitera Journal: Neurology Date: 2018-02-14 Impact factor: 9.910
Authors: Amos S Hundert; Anna Huguet; Patrick J McGrath; Jennifer N Stinson; Mike Wheaton Journal: JMIR Mhealth Uhealth Date: 2014-08-19 Impact factor: 4.773
Authors: Mia Tova Minen; John Torous; Jenelle Raynowska; Allison Piazza; Corita Grudzen; Scott Powers; Richard Lipton; Mary Ann Sevick Journal: J Headache Pain Date: 2016-05-10 Impact factor: 7.277
Authors: Mia T Minen; Kaitlyn Morio; Kathryn Berlin Schaubhut; Scott W Powers; Richard B Lipton; Elizabeth Seng Journal: Cephalalgia Date: 2019-12-23 Impact factor: 6.292
Authors: Mia T Minen; Neil A Busis; Steven Friedman; Maya Campbell; Ananya Sahu; Kazi Maisha; Quazi Hossain; Mia Soviero; Deepti Verma; Leslie Yao; Farng-Yang A Foo; Jaydeep M Bhatt; Laura J Balcer; Steven L Galetta; Sujata Thawani Journal: Digit Health Date: 2022-07-17
Authors: Mia T Minen; Benjamin W Friedman; Samrachana Adhikari; Sarah Corner; Scott W Powers; Elizabeth K Seng; Corita Grudzen; Richard B Lipton Journal: Gen Hosp Psychiatry Date: 2021-01-08 Impact factor: 3.238
Authors: Mia T Minen; Samrachana Adhikari; Jane Padikkala; Sumaiya Tasneem; Ashley Bagheri; Eric Goldberg; Scott Powers; Richard B Lipton Journal: Headache Date: 2020-11-16 Impact factor: 5.887
Authors: Bianca Raffaelli; Jasper Mecklenburg; Lucas Hendrik Overeem; Simon Scholler; Markus A Dahlem; Tobias Kurth; Ana Sofia Oliveira Gonçalves; Uwe Reuter; Lars Neeb Journal: JMIR Mhealth Uhealth Date: 2021-07-07 Impact factor: 4.773